Inducing apoptosis by the inhibition of c-myb in oral squamous carcinoma cell line, KB cell
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Oral squamous cell carcinoma (OSCC) is the most common malignancy and is a major cause of worldwide cancer mortality. The proto-oncogene c-myb plays an important role in regulation of cell growth and differentiation, and it is expressed at high levels in hematopoietic cells and many other types of cancers. However, the function of c-myb is not well known in OSCC. The present study aimed to reveal the function of c-myb and to test the alternation of cell growth and signaling by c-myb in OSCC. In this study, c-myb and dominant-negatibe myb(DNmyb) were expressed in an adenovirus-mediated gene delivery system to KB cells. The over-expressed c-myb brought increased cellular proliferation compared with control cells. However, DN-myb infected KB cells showed significant reduction of cell growth and enhanced induction of apoptosis to activate PARP and caspase 9. c-myb induced increase of IGF-I, -II and IGF-IR expressions while DN-myb down-regulated these expression. Activation of ERK and Akt/PKB pathway was shown only in c-myb transduced cells. These findings suggest that the role of c-myb in cell growth of oral cancer cells is partially mediated through the modulation of IGFs, ERK and Akt/PKB. From this results, DN-myb is strongly recommended as a curable gene for the treatment of c-myb dependent malignancies such as OSCC.
Abstract
Oral squamous cell carcinoma (OSCC) is the most common malignancy and is a major cause of worldwide cancer mortality. The proto-oncogene c-myb plays an important role in regulation of cell growth and differentiation, and it is expressed at high levels in hematopoietic cells and many other types of cancers. However, the function of c-myb is not well known in OSCC. The present study aimed to reveal the function of c-myb and to test the alternation of cell growth and signaling by c-myb in OSCC. In this study, c-myb and dominant-negatibe myb(DNmyb) were expressed in an adenovirus-mediated gene delivery system to KB cells. The over-expressed c-myb brought increased cellular proliferation compared with control cells. However, DN-myb infected KB cells showed significant reduction of cell growth and enhanced induction of apoptosis to activate PARP and caspase 9. c-myb induced increase of IGF-I, -II and IGF-IR expressions while DN-myb down-regulated these expression. Activation of ERK and Akt/PKB pathway was shown only in c-myb transduced cells. These findings suggest that the role of c-myb in cell growth of oral cancer cells is partially mediated through the modulation of IGFs, ERK and Akt/PKB. From this results, DN-myb is strongly recommended as a curable gene for the treatment of c-myb dependent malignancies such as OSCC.
참고문헌 (21)
- Gupta, "Risk factors and risk markers for oral cancer in high incidence areas of the world edited by Jhonson", pp.29~63 (1991), Cambridge University Press
- Datta, K, "AH", PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation, 1995, pp.15, 2304~2310
- Guerin, "Strong association between c-myb and estrogen-receptor expression in human breast cancer", pp.131~135 (1990)
- Howe, "Characterization of the sequence-specific interaction of mouse c-myb protein with DNA", pp.161~169 (1990)
- Ibanez, "Trans activation of gene expression by v-myb", pp.2285~2293 (1990)
- Luchetti, "The myb oncogene family of transcription factors potent regulators of hematopoietic cell proliferation anddifferentiation", pp.113~124 (1994)
- and Eisenman, "New light on Myc and Myb", pp.2235~2241 (1990)
- Ku, "Regulation of the expression of the hematopoietic stem cell antigen CD34 role of c-myb", pp.1023~1028 (1994)
- Nishina, "Trans-activation by the c-myb proto-oncogene", pp.107~117 (1989)
- Rane, S. G, "STATs and Src kinases in hematopoiesis", 21, pp.3334~3358 (2002)
- Ratajczak, "In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides", pp.11823~11827 (1992)
- Reiss, "The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism", pp.5997~6000 (1991)
- Nagase, "Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene", pp.5758~5762 (1989)
- Sala, A, "B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer", 41, pp.2479~2484 (2005)
- Saranath, D, "Integrated biology and molecular pathology of oral cancer,", pp.30~71 (2000), Oxford University Press, New Delhi
- Scharf, J.G, "The role of the IGF axis in hepatocarcinogenesis", 35, pp.685~693 (2003)
- Sitzmann, J, "Expression of mouse c-myb during embryonic development", 11, pp.2273~2279 (1995)
- Suzuki, K, "Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I", 272, pp.111~115 (2000)
- Thompson, MA, "Myb: an old oncoprotein with new roles", 17, pp.341~350 (1995)
- Torelli, "Expression of cmyb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa", pp.5266~5269 (1987)
- Yi, HK, "Induction of apoptosis in K562 cells by dominant negative c-myb", 30, pp.1139~1146 (2002)